ReviewACS pharmacology & translational science2026
Baxdrostat: A First-in-Class Aldosterone Synthase Inhibitor for Resistant Hypertension.
Imma Capriello et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it